Cynthia Collins

Shares of Editas Medicine Inc (NASDAQ: EDIT) tumbled 20 percent Tuesday after the CEO of the genome editing company announced her resignation. Editas said Katrine Bosley will step down as president, CEO and board member while board member Cynthia Collins will run the company as interim CEO. The...